2023-504630-22-00招募中2 期
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 16
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Helen Chalk
Scientific
Mythic Therapeutics Inc.
研究点 (16)
Loading locations...
相似试验
招募中
1 期
A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors previously treated with other therapies.2024-512403-39-01Abalos Therapeutics GmbH27
招募中
1 期
A Study Testing the Investigational Drug XmAb541 in people with Advanced Cancer2025-521981-90-00Xencor Inc.70
招募中
1 期
A Study of NTX-1088 as Monotherapy and Combined with Pembrolizumab2024-520077-12-00Nectin Therapeutics Ltd.10
招募中
1 期
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut AllergyNCT07287033Mabylon AG48
招募中
1 期
The effect of SYX-5219 on an immune response in the skin.2025-522217-27-00Sitryx Therapeutics Limited20